ESR1 and breast cancer: Considering the prior findings that ER-positive and HER2-negative (luminal) breast cancers are generally less aggressive than ER-negative and HER2-positive invasive breast cancers [60], the associations between linear calcifications with HER2 overexpression and negative association with ER-positivity in our review were not unexpected.